NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 85 filers reported holding NEURODERM LTD in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $3,259,000 | +12.6% | 109,000 | 0.0% | 0.26% | +10.4% |
| Q1 2017 | $2,894,000 | +31.0% | 109,000 | +9.5% | 0.24% | +17.1% |
| Q4 2016 | $2,209,000 | +38.1% | 99,500 | +15.0% | 0.20% | +38.5% |
| Q3 2016 | $1,599,000 | +13.7% | 86,500 | 0.0% | 0.15% | -11.9% |
| Q2 2016 | $1,406,000 | +15.2% | 86,500 | 0.0% | 0.17% | -1.8% |
| Q1 2016 | $1,221,000 | – | 86,500 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 826,799 | $11,674,000 | 6.53% |
| Foresite Capital Management III, LLC | 292,371 | $4,128,000 | 3.19% |
| Avoro Capital Advisors LLC | 537,477 | $7,589,000 | 2.65% |
| Redmile Group, LLC | 1,180,887 | $16,674,000 | 1.71% |
| NEXTHERA CAPITAL LP | 70,000 | $988,000 | 1.02% |
| SCOPIA CAPITAL MANAGEMENT LP | 3,383,359 | $47,773,000 | 0.89% |
| Foresite Capital Management II, LLC | 119,781 | $1,691,000 | 0.83% |
| SENZAR ASSET MANAGEMENT, LLC | 215,400 | $3,041,448,000 | 0.60% |
| SPHERA FUNDS MANAGEMENT LTD. | 166,359 | $2,349,000 | 0.51% |
| Opaleye Management Inc. | 38,500 | $544,000 | 0.34% |